|
(AFX UK Focus)
2006-06-05 14:58
Merck to file Januvia diabetes type II drug in 2006; earlier than expected |
|---|
| Article layout: raw |
|
The drug MK-0431A, is the company's investigational oral medicine combining Januvia with metformin for type 2 diabetes. newsdesk@afxnews.com ks
COPYRIGHT Copyright AFX News Limited 2005. All rights reserved. The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News. AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited |
| Production or sales statistics |
| Article layout: raw |
|